COMPANY
Abalone Bio, Inc.
NIH awards 9
- NIH award 1R43DA060776-01 FY2024: $399,230 awarded for that fiscal year; activity R43 (SBIR); PI TAKEUCHI, TOSHIHIKO; recipient as written: ABALONE BIO, INC., Emeryville, CA. A peripherally restricted MOR agonist for source ↗
- NIH award 5R44DK125191-03 FY2023: $999,999 awarded for that fiscal year; activity R44 (SBIR); PI SCHWIMMER, LAUREN JENNIFER; recipient as written: ABALONE BIO, INC., Emeryville, CA. Therapeutic antibodies for treatin source ↗
- NIH award 2R44DK125191-02 FY2022: $999,999 awarded for that fiscal year; activity R44 (SBIR); PI SCHWIMMER, LAUREN JENNIFER; recipient as written: ABALONE BIO, INC., Emeryville, CA. Therapeutic antibodies for treatin source ↗
- NIH award 1R43HD106864-01A1 FY2022: $292,942 awarded for that fiscal year; activity R43 (SBIR); PI TAKEUCHI, TOSHIHIKO; recipient as written: ABALONE BIO, INC., Emeryville, CA. Antibody agonist for a G protein-couple source ↗
- NIH award 5R44CA241513-03 FY2022: $1,063,128 awarded for that fiscal year; activity R44 (SBIR); PI SCHWIMMER, LAUREN JENNIFER; recipient as written: ABALONE BIO, INC., Emeryville, CA. Therapeutic antibodies for treat source ↗
- NIH award 2R44CA241513-02 FY2021: $915,873 awarded for that fiscal year; activity R44 (SBIR); PI SCHWIMMER, LAUREN JENNIFER; recipient as written: ABALONE BIO, INC., Emeryville, CA. Therapeutic antibodies for treatin source ↗
- NIH award 1R43DK127654-01A1 FY2021: $300,241 awarded for that fiscal year; activity R43 (SBIR); PI SCHWIMMER, LAUREN JENNIFER; recipient as written: ABALONE BIO, INC., Emeryville, CA. Therapeutic Antibodies for Treat source ↗
- NIH award 1R43DK125191-01 FY2020: $349,013 awarded for that fiscal year; activity R43 (SBIR); PI SCHWIMMER, LAUREN JENNIFER; recipient as written: ABALONE BIO, INC., Emeryville, CA. Therapeutic antibodies for treatin source ↗
- NIH award 1R43CA241513-01A1 FY2019: $299,999 awarded for that fiscal year; activity R43 (SBIR); PI PESCE, GUSTAVO; recipient as written: ABALONE BIO, INC., Emeryville, CA. Therapeutic antibodies for treating chemothe source ↗